NFG
NVCR icon

NewFocus Financial Group’s NovoCure NVCR Stock Holding History

NewFocus Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$322K Sell
1,860
-1,350
-42% -$185K 0.09% 100
2020
Q3 		$357K Buy
+3,210
New +$257K 0.12% 92

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NewFocus Financial Group's NVCR Position: Q4 2020 in Review

NewFocus Financial Group reduced its NovoCure (NVCR) stake by 42% in Q4 2020, selling an estimated $185K and leaving 1,860 shares worth $322K. The position accounts for 0.09% of the portfolio, ranked #100.

NewFocus Financial Group first reported a position in NVCR in Q3 2020 and has held it in 2 quarters since. The position peaked at $357K in Q3 2020. 357 funds tracked by Wall St. Rank hold NVCR as of Q4 2020.

  • NewFocus Financial Group held 1,860 shares of NovoCure worth $322K as of Q4 2020.
  • NewFocus Financial Group sold 1,350 NovoCure shares in Q4 2020, an estimated $185K.
  • NovoCure made up 0.09% of NewFocus Financial Group's portfolio in Q4 2020, its #100 holding.
  • NewFocus Financial Group first reported a position in NovoCure in Q3 2020 and has held it in 2 quarters since.
  • NewFocus Financial Group's NovoCure position peaked at $357K in Q3 2020.
  • 357 funds tracked by Wall St. Rank held NovoCure as of Q4 2020.

Based on NewFocus Financial Group's 13F filing for Q4 2020, filed 28 Jan 2021.